Monte Rosa Therapeutics Inc (GLUE)

Cost of Revenue

$0.00

Quarterly · Period ending: · USD

GLUE logo

GLUE Cost of Revenue

Latest reported$0.00
GLUE Quarterly Cost of Revenue ($0.00 → $0.00)
High-resolution chart · PNG

GLUE cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Monte Rosa Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
0
2,029,000
0
0
0
0
0
0
2,060,000
1,897,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.